Hepatitis C and Incarceration: Policy Proposals and Challenges

Similar documents
Hepatitis C and the Criminal Legal System

Hepatitis C Treatment for the Poor and Imprisoned: A Call to Action

Hepatitis C Screening and Treatment In U.S. Prisons: The Big Picture

Hepatitis C in Prisons: Treatment Update for Advocates

OVERVIEW OF STATE OPIOID POLICY AND LEGISLATION AMBER WIDGERY & ALISON LAWRENCE JUNE 2018

HIV CRIMINALIZATION IN OHIO. Elizabeth Bonham, JD Staff Attorney, ACLU of Ohio

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015

NASTAD AT-A-GLANCE. Britten Pund, Director, Health Care Access

September 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201

MENTALLY ILL OFFENDER TREATMENT AND CRIME REDUCTION ACT OF 2004: A POLICY ANALYSIS

Practical Solutions to Reduce Incidence of Liver Cancer. Nancy Steinfurth, Executive Director Liver Health Connection November 2017

HIV, STIGMA AND PRISON

State Approaches to Expanded Access to Sterile Syringes Through Pharmacies

Stephanie Welch, MSW Executive Officer, COMIO Office of the Secretary, Scott Kernan California Department of Corrections and Rehabilitation (CDCR)

Strategies: Reducing Disparities in Racial and Ethnic Minority Communities. Evelyn M. Foust, CPM, MPH North Carolina Communicable Disease Branch

Innovative Ways to Fund Harm Reduction Services New Mexico

HIV in Prisons,

AIDS Foundation of Chicago Strategic Vision

Miami-Dade County Getting to Zero HIV/AIDS Report

Miami-Dade County Getting to Zero HIV/AIDS Task Force Implementation Report

January XX, Vice President-elect Mike Pence Chair, Trump-Pence Transition Team Washington, DC. Dear Vice President-elect Pence:

#2015USCA

Comprehensive HIV/AIDS Resources and Linkages for Inmates (CHARLI) and Care Coordination (CC) Collaborative. Care Coordination

Health Department Role: Eliminating HBV and HCV

Treat or Repeat. A State Survey of Serious Mental Illness, Major Crimes and Community Treatment Executive Summary. September 2017


Addressing a National Crisis Too Many People with Mental Illnesses in our Jails

THE 21ST CENTURY CURES ACT: TACKLING MENTAL HEALTH FROM THE INSIDE OUT

Eliminating the Public Health Problem of Hepatitis B and C in the United States. April 10, 2017

Nebraska LB605: This bill is designed to reduce prison overcrowding and allows for alternatives to incarceration like CAM.

THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE BILL

Drug-Free Zones. A Presentation to Senate Appropriations Subcommittee on Criminal and Civil Justice. Claire K. Mazur.

Medication Assisted Treatment in the Justice System. NCSL Law, Criminal Justice and Public Safety Committee Breakfast

STATE ALZHEIMER S DISEASE PLANS: TRAINING

Forensic Patients in State Hospitals:

THE STEPPING UP INITIATIVE

FRAMINGHAM, MASSACHUSETTS JAIL DIVERSION PROGRAM

National Viral Hepatitis Roundtable (NVHR)

SACRAMENTO DEA: METHAMPHETAMINE. Intelligence Analyst Matthew S. Kregor

Responding to Homelessness. 11 Ideas for the Justice System

THE ESTIMATED ECONOMIC IMPACTS AND BENEFITS OF ACCOUNTABILITY COURT PROGRAMS IN GEORGIA EVIDENCE FROM A SURVEY OF PROGRAM PARTICIPANTS

Advocating for Syringe Exchange Programs

Viral Hepatitis in the U.S.: Federal Partner Update

An Overview of Risk-Needs- Responsivity Model: Application to Behavioral Health Populations

California's incarceration rate increased 52 percent in the last 20 years.

Improving care for pregnant people with opioid use disorder in U.S. jails: Research to implement medication assisted treatment

January 13, Dear Vice President-elect Pence:

Restructuring Proposal for the Criminal Division of the Circuit Court of Cook County

March XX, Washington, DC Washington, DC Washington, DC Washington, DC 20515

HIV Prevention, Hepatitis Programming, and Drug User Health An Integrated Service Model at SFDPH. Protecting and Promoting Health and Equity

Alabama s Emerging Hepatitis C Epidemic and Vulnerability to an Outbreak of HIV Infection Among Persons Who Inject Drugs

Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next

TUCSON CITY DOMESTIC VIOLENCE COURT

The Faces of the Opioid Crisis

Using Policy, Programs, and Partnerships to Stamp Out Breast and Cervical Cancers

Handbook Review: HOD Reference Committee D (Public Health) HOD resolution or Action requested AMA-YPS recommended report (sponsor) position

Tobacco Control Policy at the State Level. Progress and Challenges. Danny McGoldrick Institute of Medicine Washington, DC June 11, 2012

Kentucky s Plan to Address the Opioid Crisis National Statistics. Scope of the Problem 3/14/18

NORTHAMPTON COUNTY DRUG COURT. An Overview

The Current State of Crisis Intervention Teams: A National Perspective

Criminal Justice in Arizona

Effective Date: 9/14/06 NOTICE PRIVACY RULES FOR VALUEOPTIONS

The Cost of Imprisonment

Prescription for Progress Study conducted by the Siena College Research Institute April 10 - May 4, Stakeholders - MOE +/- 4.

Fact Sheet: Drug Data Summary

October 8, Michael Botticelli Deputy Director Office of National Drug Control Policy. Washington, D.C Dear Deputy Director Botticelli:

Mandating Body Mass Index Reporting in the Schools

Restrictions to HCV Treatment in State Medicaid Programs

CDC s Response to the Viral Hepatitis/Opioid Syndemic

Community-based sanctions

Overview of Evidence for Sterile Syringe Access. Hilary McQuie Western Director Harm Reduction Coalition

Correctional Medicine. By: Robert B. Pritt D.O.

2012 Medicaid and Partnership Chart

October 3, Dear Representative Hensarling:

Behavioral Health: Public Health Challenge Public Health Opportunity. Pamela S. Hyde, J.D. SAMHSA Administrator

The Healthy Indiana Plan

National Viral Hepatitis Action Plan Priority Populations Approach

Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse

BRAZOS VALLEY COUNCIL ON ALCOHOL AND SUBSTANCE ABUSE BOARD POLICY SECTION 600: CRIMINAL JUSTICE. Policy Statement

Responding to Homelessness. 11 Ideas for the Justice System

ADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians

Hepatitis B Virus and the Opioid Crisis

Fact Sheet: Drug Data Summary

HEALTHIER LIVES, STRONGER FAMILIES, SAFER COMMUNITIES:

Guam Department of Education (GDOE) Priority 2 HIV Prevention Program. Cooperative Agreement No. FOA DP08-801

Legislative Report, 2011

State-by-State Lethal Injection Information. Used One-Drug Protocol?

AUL s 2014 Life List

NCADD :fts?new JERSEY

Re-Entrenchment Through Reform: The Promises and Perils of Categorical Exemptions for Extreme Punishment Policy

Presentation at the BJS/JRSA 2010 National Conference Portland, Maine Meredith Farrar-Owens, Deputy Director Virginia Criminal Sentencing Commission

Prisoner Protections for Family and Community Health Act

Care Coach Collaborative Model Bridging Gap of Medical Linkage for HIV Positive Inmates Go home, kiss your Mother, and come into our offices. (Patsy F

Criminalization of HIV Transmission and Related Concerns

CHAPTER 1 An Evidence-Based Approach to Corrections

Marijuana - Decriminalization 1 : 2015 Legislative Session Bill Status Update

Research Memo. 4. What are the sanctions for DUI accidents resulting in serious injury and/or death?

V. OTHER WOMEN S HEALTH-RELATED SERVICES

Report of Pinellas Data Collaborative CJIS System Change Over Time 2007 Findings DRAFT

Criminal Justice in Arizona

Transcription:

Hepatitis C and Incarceration: Policy Proposals and Challenges Elizabeth Paukstis, M.A., J.D. Public Policy Director National Viral Hepatitis Roundtable April 2018 1

2 The National Viral Hepatitis Roundtable is a national coalition working together to eliminate hepatitis B and C in the United States. NVHR s vision is a healthier world without hepatitis B and C. www.nvhr.org

3 HCV and Incarceration A disproportionate number of incarcerated people have HCV. Approximately 1 in 3 individuals in U.S. jails and prisons has HCV. In state prisons, which house about 90 percent of all incarcerated people, an estimated 17 percent of inmates are infected (compared to about 1 percent of the non-incarcerated population). Sources: Bureau of Justice Statistics, National Prisoner Statistics, 2004-2014. Updated Sept. 2015; Beckman, et al. New Hepatitis C Drugs Are Very Costly And Unavailable To Many State Prisoners. HEALTH AFF 2016;35:893-1901.

Lack of treatment Very few incarcerated people with HCV receive treatment. Health Affairs study (October 2016): 32 states (65 percent) do not perform routine opt-out testing of inmates Main criteria for testing: abnormal labs, HIV, or reported substance use Only 17 states (35 percent) perform routine opt-out testing In 41 states reporting data, 106,266 of their inmates were known to have HCV on or about January 1, 2015 Less than one percent (0.89 percent) of those known to have HCV were receiving some type of treatment States reporting financial data spent a median $76,085 on Solvadi and a median $63,509 on Harvoni Source: Beckman, et al. New Hepatitis C Drugs Are Very Costly And Unavailable To Many State Prisoners. HEALTH AFF 2016;35:893-1901. 4

Some states with ongoing HCV prison litigation Alabama Braggs v. Dunn California Bayse et al v. California Dept of Corrections and Rehabilitation et al Colorado Aragon v. Raemisch Florida Hoffer v. Jones Massachusetts Paszko v. O Brien Minnesota Ligons v. Minnesota Dept of Corrections Missouri Postawko v. Missouri Dept of Corrections Pennsylvania Chimenti v. Pennsylvania Dept of Corrections Tennessee Graham v. Parker Virginia Reid v. Clarke Riggleman v. Clarke 5

6 Why won t the prisons perform HCV testing? - No incentive to test when you cannot afford to treat - Understaffed - Untrained and poorly paid staff - Privatized health care in prisons (cost savings) - Poor infrastructure

7 Why can t state prisons buy the drugs? Options for obtaining drug discounts are scarce BOP receives at least a 24 percent discount on HCV drugs (not an option for state prisons) The Medicaid best price rule: state prisons cannot negotiate below the best price offered to state Medicaid programs State prisons not eligible for discounts under the Federal 340B Drug Pricing Program (20 to 50 percent off of average wholesale price)

8 Other avenues are difficult Direct negotiations with pharmaceutical companies Must convince pharma companies that state prisons are an untapped market Partnering with FQHCs, which are eligible for 340B, to provide health care to prisoners at reduced costs Pooled procurement with other state correctional agencies to buy in bulk for a lower price

9 MISSISSIPPI: A CASE STUDY

10 Mississippi by the numbers Estimated number of people living with HCV antibodies (2010): 35,200 Number of deaths related to HCV (2014): 171 Estimated number of HCV-infected people on Medicaid or in prison (2016): 3,000 Estimated number of HCV-infected inmates (2013): 406 Number of syringe service programs (SSPs): 0 Note: Mississippi is one of several states that does not consistently report HCV data to the CDC. Sources: HepVu (www.hepvu.org). Emory University, Rollins School of Public Health, in partnership with Gilead Sciences, Inc.; Jimmie E. Gates, The Clarion- Ledger, Mississippi Has 300 Inmates with Hepatitis C, May 26, 2016; The Council of State Governments, 2013 Corrections Comparative Data Report, https://www.scribd.com/document/274299046/2013-corrections-comparative-data-report; amfar Opioid & Health Indicators Database, Mississippi Opioid Epidemic, www.opioid.amfar.org.

11 Syringe exchange In the United States, where most new HCV infections are associated with injection drug use, syringe exchange programs have particular promise to interrupt transmission. National Academies of Science, Engineering, and Medicine (2017) But In Mississippi, anyone who uses or possesses a syringe is guilty of a misdemeanor and may be incarcerated for up to 6 months, or fined up to $500, or both. Sources: The National Academies of Sciences, Engineering, and Medicine, Committee on a National Strategy for the Elimination of Hepatitis B and C, A National Strategy for the Elimination of Hepatitis B and C: Phase II Report (March 2017), http://www.nationalacademies.org/hmd/activities/publichealth/nationalstrategyfortheeliminationofhepatitisbandc.aspx.; Miss. Code Ann. 41-29-139 (2017).

12 Criminalization of HCV Once incarcerated, HCV-infected people run the risk of being charged with endangerment by bodily substance. An HCV-infected person who attempts to cause or knowingly causes a corrections employee, a visitor to a correctional facility or another prisoner or offender to come into contact with blood, seminal fluid, urine, feces or saliva is guilty of a felony. Mandatory minimum: 3 years in prison Can be imprisoned for up to 10 years, fined $10,000, or both. Note: Contact with seminal fluid, urine, feces, or saliva does not transmit HCV. Source: Miss. Code Ann. 97-27-14 (2017).

Imprisoned and untreated Mississippi has At least 400 incarcerated people with HCV No opt-out testing (so number of infected is likely higher) Fewer than 1 percent of known HCV-infected inmates (0.14 0.45%) receiving curative treatment Sources: The National Academies of Sciences, Engineering, and Medicine, Committee on a National Strategy for the Elimination of Hepatitis B and C, A National Strategy for the Elimination of Hepatitis B and C: Phase II Report (March 2017), http://www.nationalacademies.org/hmd/activities/publichealth/nationalstrategyfortheeliminationofhepatitisbandc.aspx.; Miss. Code Ann. 41-29-139 (2017). 13

Abysmal prison conditions The East Mississippi Correctional Facility (EMCF): Approximately 1200 inmates, 80% diagnosed with mental illness Privately operated by Management & Training Corporation Security staff earn less than $12 per hour Defendant in an ACLU lawsuit since 2013 It s more than inattention, it s just outrageous neglect and callousness. They can t get light bulbs. They cannot get cleaning material. The damage from the fires is not removed. The trash is not picked up. They get almost no services. They can t even get the attention of the officers. testimony of expert witness Terry Kupers Sources: Mississippi Inmates Lawsuit Describes Violence and Neglect in a Private Prison, Mother Jones, April 2018; Inside a Private Prison: Blood, Suicide and Poorly Paid Guards, New York Times, April 2018. 14

15 What can we do? Advocate changes to the Medicaid best price rule State prisons should be added as exemptions Oppose legislation that exploits the opioid crisis to reignite the War on Drugs and imprison more people Support the Reverse Mass Incarceration Act and the Sentencing Reform and Corrections Act Urge pharma companies to negotiate discounts with state prisons VOTE We got the Prison Rape Elimination Act under GWB Could we get the Prison Hepatitis Elimination Act under the right leadership?

NVHR National Viral Hepatitis Roundtable 16